BPC 157 is a pentadecapeptide that consists of 15 separate amino acids. It contains a molecular weight of 1419.53552, and its molecular formula is C62H98N16O22. It can also go by the names of BPC-157, BPC 15, and Booly Protection Compound 15. Its appearance manifests itself as a white powder.

BPC 157 at a Glance

According to scientific research conducted on animal test subjects, BPC 157 is a partial sequence of body protection compound (BPC). It can be isolated from the gastric juices that are found within the gastro-intestinal tract of the test subjects.

Scientific research has shown that the peptide has a tendency to exhibit anti-ulcer peptidergic properties. These properties allow BPC 157 to provide regulatory functions within the gastro-intestinal tract of the subjects. It has shown significant angiogenic properties, meaning that it can assist greatly in the formation of new blood vessels from pre-existing blood vessels. Furthermore, it has been shown an ability to protect the endothelium, which is the thin layer of cells that line the interior surface of blood vessels. This research has also demonstrated that the peptide carries significant anti-inflammatory qualities.

Theorized Benefits of BPC 157

Because of BPC 157’s level of regulatory functionality, scientific study based on animal test subjects has determined that the peptide can be tied to host of theoretical benefits.
The most significant benefit that has been theorized in relation to BPC 157 is the peptide’s potential aid in the combating of various gastro-intestinal ailments. Scientific study on laboratory rats have shown that BPC 157 can play a key role in lessening the effects of inflammatory bowel disease; a collective of complex vascular tissue responses that are focused around the colon and small intestine. The two main conditions tied to this group are Chron’s disease and ulcerative colitis. The former condition is a chronic inflammatory disorder that can cause abdominal pain, vomiting, diarrhea, significant weight loss, and in some cases anemia and arthritis. The latter condition is an intermittent affliction that features inflammation of the colon, the manifestation of ulcers or open sores, and constant diarrhea mixed with blood of gradual onset. Further scientific study based on animal test subjects has determined that the peptide can possibly play a significant role in lowering the effects of esophagitis; a condition that is marked by the inflammation of the esophagus and an increased difficulty in swallowing.
Another key benefit that has been theorized revolves around BPC 157’s relationship with the teeth and gums. Scientific study conducted on animal test subjects have determined that the peptide can significantly lower the effects of periodontitis; a group of inflammatory diseases that affect the tissues and support around the teeth.